業績

2013年

  1. Nitta K, Okada K, Yanai M, Takahashi S. Aging and chronic kidney disease. Kidney Blood Press Res. 2013;38(1):109-20.
  2. Kawanishi K, Sawada A, Ochi A, Moriyama T, Mitobe M, Mochizuki T, Honda K, Oda H, Nishikawa T, Nitta K. Glomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature. Case Rep Nephrol Urol. 2013 Nov 28;3(2):128-35.
  3. Kawanishi K, Yamato M, Sakiyama R, Okano T, Nitta K. Peritoneal cell sheets composed of mesothelial cells and fibroblasts prevent intra-abdominal adhesion formation in a rat model. J Tissue Eng Regen Med. 2013 Dec 10. doi: 10.1002/term.1860. [Epub ahead of print] PMID: 24323675
  4. Shimizu A, Takei T, Moriyama T, Itabashi M, Uchida K, Nitta K. Clinical and pathological studies of IgA nephropathy presenting as a rapidly progressive form of glomerulonephritis. Intern Med. 2013;52(22):2489-94.
  5. Koike M, Nitta K. [Treatment of hypertriglyceridemia: plasma exchange]. Nihon Rinsho. 2013 Sep;71(9):1667-9. Review. Japanese.
  6. Otani Y, Otsubo S, Kimata N, Takano M, Abe T, Okajima T, Miwa N, Tsuchiya K, Nitta K, Akiba T. Effects of the ankle-brachial blood pressure index and skin perfusion pressure on mortality in hemodialysis patients. Intern Med. 2013; 52(21): 2417-21.
  7. Kimata N, Wakayama K, Okano K, Hibi A, Sawada A, Tajima Y, Makabe S, Tsuchiya K, Mineshima M, Nitta K, Akiba T. Study of discrepancies between recorded and actual blood flow in hemodialysis patients. ASAIO J. 2013 Nov-Dec;59(6):617-21.
  8. Hara M, Ando M, Morito T, Nokiba H, Iwasa Y, Tsuchiya K, Nitta K. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease. Nephron Clin Pract. 2013;123(3-4):202-8.
  9. Yamashita T, Ogawa T, Takahashi M, Mitsuhashi T, Shizuku J, Takahashi N, Ohba T, Miyajima S, Kabaya T, Otsuka K, Nitta K. Additional reduction in serum phosphorus levels by pulverized lanthanum carbonate chewable in hemodialysis patients. Ther Apher Dial. 2013 Apr;17 Suppl 1:54-9.
  10. Yajima A, Inaba M, Tominaga Y, Tanaka M, Otsubo S, Nitta K, Ito A, Satoh S. Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease. Ther Apher Dial. 2013 Apr;17 Suppl 1:41-8.
  11. Sato K, Ishida H, Uchida K, Nitta K, Tanabe K. Risk factors for recurrence of immunoglobulin a nephropathy after renal transplantation: single center study. Ther Apher Dial. 2013 Apr;17(2):213-20.
  12. Muramatsu T, Yanagisawa N, Chikasawa Y, Seita I, Yotsumoto M, Otaki M, Ogata K, Hagiwara T, Suzuki T, Suganuma A, Imamura A, Amano K, Yamamoto Y, Nitta K, Ajisawa A, Fukutake K, Ando M. [Prevalence of chronic kidney disease among HIV-infected individuals in Japan--a report from two tertiary hospitals]. Kansenshogaku Zasshi. 2013 Jan;87(1):14-21. Japanese.
  13. Hanaoka M, Gono T, Kawaguchi Y, Uchida K, Koseki Y, Katsumata Y, Kaneko H, Takagi K, Ichida H, Nitta K, Yamanaka H. Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. Rheumatology (Oxford). 2013 Dec;52(12):2149-57.
  14. Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A; Chronic Kidney Disease Japan Cohort Study Group. Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol. 2013 May;8(5):721-30.
  15. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry; Japanese Society of Nephrology. Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol. 2013 Apr;17(2):155-73.
  16. Tsuchiya K, Nitta K. Hepcidin is a potential regulator of iron status in chronic kidney disease. Ther Apher Dial. 2013 Feb;17(1):1-8. doi: 10.1111/1744-9987.12001. Epub 2012 Dec 16. Review.
  17. Hara M, Nemoto T, Hijima T, Tsuchiya K, Nitta K, Ando M. A case of IgA nephropathy associated with mycosis fungoides that developed into rapidly progressive glomerulonephritis. Clin Nephrol. 2013 Feb;79(2):161-5.
  18. Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol. 2013 Oct;17(5):730-42.
  19. Moriyama T, Iwasaki C, Tanaka K, Ochi A, Shimizu A, Shiohira S, Itabashi M, Takei T, Uchida K, Tsuchiya K, Nitta K. Effects of combination therapy with renin-angiotensin system inhibitors and eicosapentaenoic acid on IgA nephropathy. Intern Med. 2013;52(2):193-9. Epub 2013 Jan 15.
  20. Yanagisawa N, Ando M, Tsuchiya K, Nitta K. Impact of cystatin C elevation and albuminuria on probability of adverse outcomes in HIV-infected men receiving HAART. Clin Nephrol. 2013 May;79(5):362-9.
  21. Takei T, Itabashi M, Moriyama T, Kojima C, Shiohira S, Shimizu A, Tsuruta Y, Ochi A, Amemiya N, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrol Dial Transplant. 2013 May;28(5):1225-32.
  22. Yamagata K, Usui J, Sugiyama H, Nitta K, Wada T, Muso E, Arimura Y, Koyama A, Makino H, Matsuo S. Clinical findings on ANCA-associated renal vasculitis from the Japan RPGN registry obtained via a questionnaire survey. Clin Exp Nephrol. 2013 Oct;17(5):646-9.
  23. Mochizuki T, Tsuchiya K, Nitta K. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol. 2013 Jun;17(3):317-26.
  24. Kohei J, Ishida H, Tanabe K, Tsuchiya K, Nitta K. Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation. Int Urol Nephrol. 2013 Aug;45(4):1159-67.
  25. Amemiya N, Otsubo S, Iwasa Y, Onuki T, Nitta K. Association between high-molecular-weight adiponectin and bone mineral density in hemodialysis patients. Clin Exp Nephrol. 2013 Jun;17(3):411-5.
  26. Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int. 2013 May-Jun;33(3):242-51.
  27. Tsuruta Y, Okano K, Kikuchi K, Tsuruta Y, Akiba T, Nitta K. Effects of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism. Clin Exp Nephrol. 2013 Feb;17(1):120-6.
  28. Ochi A, Moriyama T, Takei T, Uchida K, Nitta K. Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol. 2013 Apr;45(2):469-76.
  29. Takei T, Itabashi M, Moriyama T, Shimizu A, Tsuruta Y, Ochi A, Nakayama K, Iwasaki C, Uchida K, Nitta K. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis. Clin Exp Nephrol. 2013 Feb;17(1):92-8.
  30. Saito T, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan. Heart Vessels. 2013 May;28(3):323-9.
  31. Yamashita T, Okano K, Tsuruta Y, Akiba T, Nitta K. Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients. Int Urol Nephrol. 2013 Feb;45(1):207-14.